Patients with rheumatic diseases are concerned about their medications increasing the risk of COVID-19 disease, particularly those on combination csDMARDs or a b/tsDMARD, Australian research shows. A survey of 550 patients at the Monash Health Department of Rheumatology Department found that 56% were concerned that their medications would increase their risk of contracting COVID-19, and ...
Patients anxious about DMARDs and COVID-19 risk
By Michael Woodhead
22 Jun 2020